Semiconductor technology is becoming increasingly important in global healthcare; enabling novel understanding, discovery and treatment of disease to make healthcare more affordable and efficient, both in and out of the clinic. With the global healthcare industry being valued at US $1.65 trillion in 2016 and expected to reach US $2.69 trillion by 20251, it is an important growing industry. Key drivers behind this ongoing market growth are growing and ageing populations, over urbanization and rising disease prevalence. All of which are putting further strain on our healthcare systems which are already grappling with issues relating to access, quality, and cost. Convergence of technology from the seemingly disparate fields of semiconductor device processing and life sciences are fast revolutionising healthcare and medical research by enabling quick and accurate diagnosis. This in turn is increasing the speed and efficiency of treatment for various conditions as well as biomedical research and development.
In the previous editions of this white paper series we delved into the various aspects of plasma processing techniques, from microfluidic channel creation and surface wettability control to creation of active electronic, photonic and MEMS devices for biomedical applications. These processes outline the breadth of Oxford Instruments’ process capabilities to design and tailor devices based on the requirements of wide variety of end applications. (Access parts 1-3 here)
Want to know more? Click here to read the full article.
This information has been sourced, reviewed and adapted from materials provided by Oxford Instruments Plasma Technology.
For more information on this source, please visit Oxford Instruments Plasma Technology.